Detalles de la búsqueda
1.
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.
Clin Infect Dis
; 61 Suppl 5: S554-62, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553688
2.
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Clin Infect Dis
; 61 Suppl 5: S514-20, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553683
3.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Clin Infect Dis
; 61 Suppl 5: S521-30, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553684
4.
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
N Engl J Med
; 364(24): 2293-304, 2011 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21675889
5.
No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
Clin Infect Dis
; 41(7): 991-7, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16142664
6.
Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.
AIDS
; 16(10): 1421-3, 2002 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12131220
7.
The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.
Vaccine
; 32(33): 4220-7, 2014 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24863486
8.
Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.
Vaccine
; 30(45): 6456-60, 2012 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22898557
9.
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
Vaccine
; 25 Suppl 1: A101-7, 2007 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-17532101
10.
Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
J Infect Dis
; 193(5): 607-16, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16453255
11.
Assignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992.
Clin Diagn Lab Immunol
; 9(3): 725-6, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11986287
12.
Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively.
J Trauma
; 53(6): 1037-42, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12478024
13.
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
Clin Diagn Lab Immunol
; 11(1): 137-41, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14715560
14.
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
J Infect Dis
; 190(7): 1228-36, 2004 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15346332
15.
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.
Emerg Infect Dis
; 8(10): 1039-43, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12396912
16.
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.
Emerg Infect Dis
; 8(10): 1066-72, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12396917
17.
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
Emerg Infect Dis
; 8(10): 1103-10, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12396924
Resultados
1 -
17
de 17
1
Próxima >
>>